D-cycloserine and social skills training in autism: what one study found
NeuroDifferent Research Digest
In one sentence
This review found no clear evidence that adding D-cycloserine to social skills training helped autistic children improve communication or social interaction.
What the researchers did
Some scientists have wondered whether certain medications could help the brain learn social skills more effectively during therapy.
One of those medications is D-cycloserine. It affects brain signaling connected to learning and memory, so researchers tested whether it might make social skills training more effective for autistic children.
The Cochrane team searched medical studies up to November 2020 and found only one study that met strict scientific standards.
In that U.S. study, 67 autistic children aged 5 to 11 took part in social skills training for ten weeks. Some children also received low-dose D-cycloserine, while others received a placebo instead. Researchers then compared how the groups were doing one week after treatment ended.
What they found
The results did not show a clear benefit from adding D-cycloserine.
Children who received the medication did not clearly improve more than the placebo group in social interaction, communication difficulties, repetitive behaviors, or overall improvement ratings.
The study also did not find major differences in serious side effects or in how many children stopped treatment early.
Because the evidence came from only one relatively small study, the review rated confidence in the findings as low.
What this means for families and therapists
At the moment, this review does not support D-cycloserine as a proven add-on treatment for helping autistic children develop social communication skills.
Families may still come across articles or online discussions about medications that affect learning in the brain. This study is a reminder that ideas that sound promising in theory do not always lead to clear real-world improvements.
For therapists and educators, the main takeaway is that structured teaching, practice, and supportive environments remain the most evidence-based tools for building communication and social skills.
Limitations and what we don't know yet
This review was based on only one study with 67 children, so the evidence is still very limited.
Researchers also looked only at short-term outcomes shortly after treatment ended. We still do not know whether different doses, longer treatment, older age groups, or combining the medication with other therapies could lead to different results.
Future studies may change the picture, but for now there is not enough evidence to recommend D-cycloserine as a standard autism treatment.
This is a plain-language summary of The effectiveness and adverse effects of D-cycloserine compared with placebo on social and communication skills in individuals with autism spectrum disorder by Aye S.Z, Ni H, Sein H.H, Mon S.T, Zheng Q, Wong Y.K.Y, Cochrane Database of Systematic Reviews (2021).
Source license: CC-BY-NC-4.0.
It is not medical advice — talk to a qualified clinician before changing therapy.